Patent intelligence · US
US 9981092
Pressurised metered dose inhalers and method of manufacture
Pressurised metered dose inhalers and method of manufacture
Patent details — US 9981092
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 29, 2018
- Expiration
- May 24, 2038
- Applicant
- Cardiff Scintigraphics Limited
- Claims
- 27
- CPC classes
- A61K, A61K9/0073, A61K9/008, A61K9/2009
Quick answer
US 9981092 (Pressurised metered dose inhalers and method of manufacture) is held by Cardiff Scintigraphics Limited. Status: granted. Granted May 29, 2018. Expires May 24, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Cardiff Scintigraphics Limited
- Grant date
- Expiration
- Claims
- 27
- CPC classes
- A61K, A61K9/0073, A61K9/008, A61K9/2009, A61K9/2013, A61K9/2018
More from Cardiff Scintigraphics Limited
Related pharmaceutical patents in our USPTO index.
-
US 12383540
Compounds that modulates AMPA receptor function
granted -
US 12318418
Modified adenoviruses
granted -
US 12263173
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12144813
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12053513
Cancer-specific T-cell receptors
granted -
US 11957677
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
granted -
US 11850264
Gamma delta T-cell receptor and its ligand
granted -
US 11725039
α/β t-cell receptor and methods of using it
granted
Frequently asked questions
What is US patent 9981092?
US 9981092 (Pressurised metered dose inhalers and method of manufacture) is held by Cardiff Scintigraphics Limited. Status: granted. Granted May 29, 2018. Expires May 24, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9981092?
Cardiff Scintigraphics Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 69 pharmaceutical patents for this assignee.
When does US 9981092 expire?
Our index shows an expiration date of May 24, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.